drugset / Trial / NCT01620762

Phase III Cat-PAD Study

NCT01620762 ↗

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to compare the treatment effect of two treatment regimens of Cat-PAD vs placebo and to evaluates the treatment effect of Cat-PAD on symptoms, rescue medication usage and Quality of Life.

Timeline

Start
2012-10
Primary completion
2016-06
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject Cat-PAD Peptide — —

Indications